147 related articles for article (PubMed ID: 8468989)
1. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
[TBL] [Abstract][Full Text] [Related]
2. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
Kroon BB; Schraffordt Koops H
Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival after isolated limb perfusion for malignant melanoma.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
Eur J Surg Oncol; 2003 Dec; 29(10):916-21. PubMed ID: 14624788
[TBL] [Abstract][Full Text] [Related]
4. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities.
Schraffordt Koops H; Kroon BB; Oldhoff J; Hoekstra HJ
World J Surg; 1992; 16(2):241-5. PubMed ID: 1561805
[TBL] [Abstract][Full Text] [Related]
5. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
Koops HS; Vaglini M; Suciu S; Kroon BB; Thompson JF; Göhl J; Eggermont AM; Di Filippo F; Krementz ET; Ruiter D; Lejeune FJ
J Clin Oncol; 1998 Sep; 16(9):2906-12. PubMed ID: 9738557
[TBL] [Abstract][Full Text] [Related]
7. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)].
Schraffordt Koops H; Oldhoff J
Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325
[TBL] [Abstract][Full Text] [Related]
8. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
9. Regional chemotherapy for melanoma. A 35-year experience.
Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O
Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.
McBride CM; Sugarbaker EV; Hickey RC
Ann Surg; 1975 Sep; 182(3):316-24. PubMed ID: 1164059
[TBL] [Abstract][Full Text] [Related]
11. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.
Sugarbaker EV; McBride CM
Cancer; 1976 Jan; 37(1):188-98. PubMed ID: 1247954
[TBL] [Abstract][Full Text] [Related]
12. [Clinical results of extremity perfusion in malignant melanoma].
Huber R; Stützer H; Krüger I
Zentralbl Chir; 1996; 121(3):234-42. PubMed ID: 8867351
[TBL] [Abstract][Full Text] [Related]
13. Isolated limb perfusion with melphalan in the treatment of malignant melanoma.
Bulman AS; Jamieson CW
Br J Surg; 1980 Sep; 67(9):660-2. PubMed ID: 7427069
[TBL] [Abstract][Full Text] [Related]
14. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion.
Klaase JM; Kroon BB; van Geel AN; van Wijk J; Franklin HR; Eggermont AM; Hart AA
J Am Coll Surg; 1994 Jun; 178(6):564-72. PubMed ID: 8193749
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.
Klaase JM; Kroon BB; van Geel AN; Eggermont AM; Franklin HR; Hart AA
Surgery; 1994 Jan; 115(1):39-45. PubMed ID: 8284759
[TBL] [Abstract][Full Text] [Related]
16. Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.
Deroose JP; Grünhagen DJ; Eggermont AM; Verhoef C
Melanoma Res; 2015 Oct; 25(5):427-31. PubMed ID: 26110555
[TBL] [Abstract][Full Text] [Related]
17. [Regional chemotherapy--perfusion of the extremities].
Meyer T; Göhl J
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
[TBL] [Abstract][Full Text] [Related]
18. Effective therapy: repeat limb perfusion for recurrent melanoma.
Krementz ET
J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
[No Abstract] [Full Text] [Related]
19. Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision alone.
Edwards MJ; Soong SJ; Boddie AW; Balch CM; McBride CM
Arch Surg; 1990 Mar; 125(3):317-21. PubMed ID: 2306179
[TBL] [Abstract][Full Text] [Related]
20. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
Alrich EM; Manwaring JL; Horsley JS
Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
